AMICUS THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Amicus Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Amicus Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$13.3M, a 70.1% decline year-over-year.
  • Amicus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $61.7M.
  • Amicus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.46M, a 104% decline from 2021.
  • Amicus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $212M, a 19.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $61.7M +$69.1M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$7.46M -$220M -104% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $212M -$50.8M -19.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $263M +$45.4M +20.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $218M -$233M -51.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $451M +$203M +82.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $247M -$25.3M -9.27% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $273M -$18.2M -6.25% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $291M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2011 -$934K -$44.6M -102% Jan 1, 2011 Dec 31, 2011 10-K 2012-02-28
2010 $43.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.